Physician profile
Nancy C Buckner
NPI 1467413369
$1,420.51
in general payments reported to CMS, 2019-2025
17 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $257 · 2021: $208 · 2022: $323 · 2023: $202 · 2024: $143 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439 · Education: $46.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.58 |
| Education | $46.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $418.68 | 2020-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $196.65 | 2019-2025 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $178.38 | 2020-2022 | |
| Tris Pharma INC | $161.58 | 2019-2023 | Dyanavel Xr |
| Otsuka America Pharmaceutical, INC. | $128.96 | 2019-2025 | Rexulti, Abilify Mycite |
| Ironshore Pharmaceuticals INC. | $52.33 | 2020-2022 | |
| Supernus Pharmaceuticals, INC. | $51.17 | 2021-2022 | |
| Corium, LLC | $39.99 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $39.35 | 2019 | |
| Shire North American Group INC | $37.31 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.81 | 2022 | |
| Noven Therapeutics, LLC | $19.15 | 2025 | Xelstrym |
| Alkermes, INC. | $17.97 | 2023 | Lybalvi |
| Vanda Pharmaceuticals INC. | $16.86 | 2022 | |
| Adlon Therapeutics L.P. | $15.26 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $13.19 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Buckner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.